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Abstract
Background: The Chinese National Infrastructure of Cell Line stores and distributes cell lines for biomedical research
in China. This study aims to represent and integrate the information of NICR cell lines into the community-based Cell
Line Ontology (CLO).
Results: We have aligned, represented, and added all identified 2704 cell line cells in NICR to CLO. We also proposed
new ontology design patterns to represent the usage of cell line cells as disease models by inducing tumor formation
in model organisms, and the relations between cell line cells and their expressed or overexpressed genes or proteins.
The resulting CLO-NICR ontology also includes the Chinese representation of the NICR cell line information. CLO-NICR
was merged into the general CLO. To serve the cell research community in China, the Chinese version of CLO-NICR
was also generated and deposited in the OntoChina ontology repository. The usage of CLO-NICR was demonstrated
by DL query and knowledge extraction.
Conclusions: In summary, all identified cell lines from NICR are represented by the semantics framework of CLO and
incorporated into CLO as a most recent update. We also generated a CLO-NICR and its Chinese view (CLO-NICR-Cv).
The development of CLO-NICR and CLO-NIC-Cv allows the integration of the cell lines from NICR into the
community-based CLO ontology and provides an integrative platform to support different applications of CLO in
China.
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Background
Cell lines are important biological materials for biomedi-
cal research on studying specific cell functions, identifying
biomarkers and searching new therapeutic methods for
various diseases. Unfortunately, cell line misidentifica-
tion and cross-contamination often occurs and affects
scientific reproducibility [1]. Cell line depositories, such
as American Type Culture Collection (ATCC) (http://
www.atcc.org/), Coriell Cell Repositories (https://catalog.
coriell.org/) and the Japanese Collection of Research
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Resources Bank (JCRB) (http://cellbank.nibiohn.go.jp),
provide well-characterized and authenticated cells for
usage in biomedical research [2].
The Chinese National Infrastructure of Cell Line
Resource (NICR) (http://www.cellresource.cn/) is a non-
profit, national cell line repository, constituted by 6 local
repositories resources from different research institutes
and with real biological cell samples for sales and an inte-
grated unified cell line categories system, which provides
quality-controlled cell lines and associated quality con-
trol service in China [3]. Similar to the Global Bioresource
Center (https://www.atcc.org/), NICR is responsible for
distributing cell line cells to its customers primarily in
China. NICR also maintains the digital cataloging of cell
line entries. We have clarified this in our revision. By
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now, NICR offers 2704 cell lines (not including stem
cell lines). Meanwhile, NICR also devotes its energy
into the normalized cell line description [4]. First, NICR
has assigned an internal unique and persistent identi-
fier for every cell line. Second, NICR has established the
Chinese - English naming rules for cell lines. The com-
plete information of a cell line in NICR includes the
cell line name, a brief introduction of one cell line, the
information about species, disease type, genetic modifi-
cation and its original cell (tissue). Control vocabulary
is required in NICR to represent the cell line informa-
tion. For example, the cell line related diseases should
be recorded by WHO international Classification of
Diseases-10 (ICD-10). Third, NICR has constructed the
annotation metadata and administrative metadata of cell
line [4]. These standardization efforts make it possible
to effectively integrate Chinese cell line information with
the Cell Line Ontology (CLO), an international cell line
standard [5].
CLO is a comprehensive community-based ontology
in the area of cell lines and cell line cells, developed
by following the principles (e.g., openness and collabo-
ration) of the Open Biological and Biomedical Ontolo-
gies (OBO) Foundry [6]. CLO reuses terms from many
existing ontologies, such as the Cell Ontology (CL) [7],
Ontology for Biomedical Investigations (OBI) [8], and
Disease Ontology [9]. CLO currently represents nearly
40,000 cell lines, whose information was extracted from
resources such as ATCC [10], HyperCLDB [11], Coriell
Cell lines, and Japan Riken cell lines (http://cell.brc.riken.
jp/en/). CLO has been used in many biomedical databases
and research projects, such as ChEMBL database [12],
the Library of Integrated Network-Based Cellular Sig-
natures (LINCS) and Cellosaurus (http://web.expasy.org/
cellosaurus/). It has also mapped to other cell line
nomenclatures such as the Experimental Factor Ontology
(EFO) [13].
To better integrate NICR cell lines with the international
cell line community, we have applied the CLO design
pattern to reformat all the NICR cell lines, and added
the information to CLO. We generated a Chinese and
English bilingual CLO subset, called CLO-NICR, which
contains all our NICR cell line cell information. Compared
with the source CLO, CLO-NICR inherits a slim bilingual
CLO framework extracted from source CLO (about 2050
classes), and includes the newly built 2704 NICR cell line
cell classes, with more cell annotation properties added in
bilingual presentation; more protein and gene classes and
the tumor formation model of cell transplantation in vivo
together with the related object properties were integrated
to the subset to extend the original CLO design pattern. In
addition, we presented a Chinese version of CLO-NICR,
i.e. CLO-NICR-Cv, in MedPortal [14], a new Chinese-
focused ontology portal generated as part of the recently
initiated OntoChina, a newly initiative program aimed at
coordinating the research, development, and applications
of biomedical ontologies in China [15].
Methods
NICR data collection and cleaning
The physical cells of NICR are distributed in 6 individual
centers in China, which are considered as the branches
of NICR. The data of all these cells are collected, stored,
and queriable in NICR of the Institute of Basic Medical
Sciences, Chinese Academy of Medical Sciences, Beijing,
China. The cell lines and their characteristics from NICR
online database were extracted automatically and stored
in EXCEL files, following a manually review and cleaning.
It should be noted that the above data of the cells charac-
teristics are originally recorded in Chinese. We translated
the data from Chinese into English, and used the bilingual
data to prepare for the construction of CLO-NICR using
both languages.
CLOmapping and collection
In NICR, the information of each cell line cell is expressed
in the format illustrated as: “ ;SW480
[SW 480; SW-480]”, where the Chinese name is the cell
type (i.e., human colon cancer cell) of the cell line SW480,
followed by the cell line label SW480 and its alterna-
tive names. Based on this format, we developed a soft-
ware program to automatically extract all the cell line
names involved in the corresponding Chinese standard-
ized name, such as “SW480”, “SW 480”, and “SW-480”
in the former example. Then, we compared them with
the labels or synonyms of all the cell line cells in CLO,
and screened out the related CLO classes with the fol-
lowing procedure. For those cell line cells with exact
mapping, the corresponding equivalent class information
was extracted automatically first with a small VBA soft-
ware program. For those cell line cells where we could not
find exact mapping, we identified the information through
manual search and evaluation based on the results identi-
fied from the NCBO BioPortal [16], Cellosaurus (https://
web.expasy.org/cellosaurus/), and Ontobee [17]. The final
identified ontology mapping information was gathered
together and used for further processing as described
below.
Construction of the CLO subset for NICR
The CLO-NICR is aligned with and extends the frame-
work of the international CLO ontology. With the col-
lected CLO mapping relations in section B, we first used
theOntofox tool [18] to obtain a simplified version of CLO
with top level classes and properties and the CLO cell line
cell classes mapped to NICR cells, to start the genera-
tion of the basic framework of CLO-NCLR and facilitate
the subsequent mapping and integration of NICR cells to
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CLO. The Protégé-OWL editor [19] was used for manual
ontology editing.
In manual data mining of characteristics entries,
a large amount of annotation information (e.g., pro-
teins and genes expressed or overexpressed in cell line
cells) was obtained. Our CLO-NICR includes extra
information not covered by the original CLO frame-
work. To incorporate many new cell line-related fea-
tures into the ontology, we extended the basic CLO
design pattern through discussions and communications
with CLO developers and ontology experts, including
Dr. He (an active CLO developer and a co-author of
this paper).
Based on the obtained mapping relations and the
extended CLO-NICR design pattern, the NICR-specific
cell classes were built according to former mapping rela-
tions. In view of the reuse of the annotation properties
for presenting of the 19 cell characteristics, a screening
for exact annotation property for the above characteris-
tics was performed, resulting in the discovery of many
existing properties in CLO and other ontologies, such
as “STR profile” in CLO and the general “rdfs:comment”,
which can be used to directly describe the “STR” and
“Comment” entries. To present the remaining cell charac-
teristics, some novel annotation attributes were generated
with a new CLO ID and extended to cover the rest entries,
such as annotation property “karyotype” used to describe
the number and appearance of chromosomes within the
nucleus of a eukaryotic cell. By using an internally devel-
oped customized Java program based on OWL API, the
properties information stored in EXCEL file and some
related entities were inserted into the general CLO-NICR
framework.
Integration the mappings relation with other ontology
We used ‘rdfs:seeAlso’ annotation property from the Infor-
mation Artifact Ontology (IAO) (https://github.com/
information-artifact-ontology/IAO) to present equivalent
mapping relations in other ontologies, and applied
‘has_broad_synonym’ annotation property to depict other
mapping relations.
CLO-NICR availability
The source code for CLO-NICR is available on the CLO
GitHub website: https://raw.githubusercontent.com/CLO-
ontology/CLO/master/src/ontology/CLO-NICR.owl.The
CLO-NICROWLfilewas alsodeposited in Ontobee (http://
www.ontobee.org/ontology/CLO-NICR), and could be
used to query on the Ontobee SPARQL Web program
(http://www.ontobee.org/sparql) [17].
MedPortal display of CLO-NICR
MedPortal (http://medportal.bmicc.cn) is a mirror of
NCBO BioPortal [16] in China. MedPortal has been
developed for the storage, analysis and visualization of
ontologies targeted for Chinese users. To promote the
open and share of CLO-NICR, we have first generated
the Chinese view of the CLO-NICR (CLO-NICR-Cv)
by using an internally developed Java software program.
CLO-NICR-Cv contains only Chinese annotation of the
cell lines in NICR. CLO-NICR-Cv was deposited into the
MedPortal triple store. The information of CLO-NICR-
Cv can then be displayed, retrieved, and analyzed in the
MedPortal website (http://medportal.bmicc.cn/).
Results
Collected and processed NICR cell line data
We collected the information of the 2704 cells and
19 characteristics involved in the description of each
cell in NICR. These cells were derived from 94
organisms. Among these cells are 917 hybridoma
cells.
CLO-NICR includes 19 annotation types for annotating
cell line cells. Each annotation type can be described
in in both English and Chinese (Fig. 1). For Chinese
users, it is often preferred to read in Chinese. There-
fore, we tried to annotate each CLO-NICR term with
a Chinese and an English presentation respectively.
For example, the English term ‘NICR cell’ can also be
expressed as the Chinese term ‘NICR14 ’, both
having the same ontology ID of CLO_0052087. To sep-
arate the expression of the term in these two languages,
we used the W3C-specified xml:lang (https://www.
w3.org/TR/xml11/). This solution is aligned with the
suggestion provided by the OBO Foundry. In our case,
“en” is used for English and “zh” for Chinese as shown
below:
< rdfs : label xml : lang =“en”> NICR14 cell < /rdfs :
label >
< rdfs : label xml : lang =“zh”> NICR14 < /rdfs :
label >
The default display of English or Chinese version in
Protégé can be set up by changing the Protégé Renderer
preferences.
Among all CLO-NICR cells, 1234 cells have CLO
mappings. Our CLO and NICR term mapping relations
includes direct CLO mappings and indirect CLO map-
pings. As an example of the direct CLOmapping, NICR14
cell (i.e. “NICR14 ” in Fig. 1) in NICR is mapped
to MDA-MB-231 cell in CLO (CLO_0007634) with exact
the same cell label. In one of previous CLO paper [20],
Japan cell bank cell line cell terms (e.g., term labels
“RCB1648 cell” and “RCB1886 cell”) were asserted as sub-
classes of the corresponding CLO terms (e.g., term label
with ID CLO_0003704) with the consideration that these
two Japan cell bank cell line cell types may have genetic
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Fig. 1 Annotation updates and enrichment in CLO-NICR. The updates and enrichment mainly came from the entities from Ontology of Genes and
Genomes (OGG) and Protein Ontology (PR), and some newly added properties and annotations. The annotation properties and axioms were
bilingual presented
variations in their long time of passages. Using the same
strategy, we asserted the NICR14 cell as a subclass for
MDA-MB-231 cell (i.e. “MDA-MB-231 ” in Fig. 1) in
CLO-NICR.
As an example of our indirect CLO mapping, we
found that NICR2026 cell (i.e. “NICR2026 ” in
Fig. 1), namely MDA-MB-231-GEP cell, as a MDA-MB-
231 derived cell line in which GFP protein are stable
transfected and overexpressed. We could not find the
direct mapping class, MDA-MB-231 derived cell line
cell in source CLO, but we could identify the indirect
mappings between NICR2026 cell andMDA-MB-231 cell.
So for these cases, we generated a new sibling class,
such as MDA-MB-231 derived cell line cell (i.e. “MDA-
MB-231 ” in Fig. 1), of the existing cell
line class, such as MDA-MB-231 cell in CLO, and then
added its children, such as NICR2026 cell, as a sub-
class of the newly built MDA-MB-231 derived cell class
in Fig. 1 [5]. And for the rest 1470 cells with no CLO
mapping data but some having mapping relations with
other ontologies and databases, we could integrate them
into general CLO framework by identifying them as the
subclass of finite cell line cell, immortal cell line cell
or hybridoma cell line cell owing to limited disclosed
information.
CLO ontology design pattern extension and usage
Depending on the original design pattern of CLO [5] we
can obtain the following typical expression (Fig. 2a):
‘cell line cell’: ‘derives from’ some (‘anatomical structure’
‘part of ’ some (‘organism’ and (‘has disease’ some disease)))
A newly published paper also introduces an extension of
the CLO design pattern, where a shortcut relation ‘derives
from patient having disease’ is used to indicate the rela-
tion between the organism and disease [20]. Based on
this model, we can say that ‘MDA-MB-231 cell’ ‘derives
from patient having disease’ ‘adenocarcinoma’ (Fig. 2b). In
biomedical research, cell lines are frequently used as mod-
els for cancer research. For example, MDA-MB-231 cell
has been used as model to study adenocarcinoma forma-
tion [21]. To represent such information, we can use the
CLO relation ‘is disease model for’. For example, we can
prepare an axiom:
Compared to these original CLO design patterns, our
extended design pattern includes more semantic rela-
tions that represent how a cell line cell is used as a
model to study cancer, Specifically, a cell line cell can
be transplanted into an organism (e.g., mouse), and grow
into a tumor under a specific experimental condition.
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Here, we used the organism1 to denote the cancer devel-
oped naturally in animal bodies, undergone the process
of transformation of normal cell into cancer cell with-
out any intended manual operation inference, while that
for ‘organism2’ are transplant recipients for cell line cells
in creating transplantation models. And the transplanted
target sites in the animals are chose manually, and the
recipient animals are usually model organism of no cancer
formation before transplantation. And in most transplant
models, the cell line cell source organism is different
from the transplantation recipient organisms. In this case,
the cell line cell participates in a ‘cell line cell-induced
tumor formation’ process that simulates cancer forma-
tion in cell line cell manual transplantation in model
organisms. To fully annotate the relation between ‘cell
line cell-induced tumor formation’ and ‘cancer’, we cre-
ated a shortcut relation, ‘simulates the realization of ’, and
the related entities can be logically represented as shown
in Fig. 2a:
‘cell line cell’: ‘participates in’ some (‘cell line cell-induced
tumor formation’ and ((‘occurs in’ some ‘organism’) and
‘simulates the realization of ’ some ‘cancer’))
For example, MDA-MB-231 cell can grow and develop
into adenocarcinoma in the nude mouse [21]. Based on
the above general design pattern, we can develop an axiom
as follows:
‘MDA-MB-231 cell’: ‘participates in’ some (‘cell line cell-
induced adenocarcinoma formation in nude mouse’ and
Fig. 2 CLO-NICR design pattern and its illustration. a An extended general CLO design pattern. b An illustration of the CLO-NICR design pattern with
MDA-MB-231 cell. Blocks in grown are entity and relations showed in original CLO design pattern. Blocks in blue are newly developed pattern
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((‘occurs in’ some ‘nude mouse’) and (‘simulates the realiza-
tion of ’ some ‘adenocarcinoma’)))
NICR and ATCC often provide the information of
expressed or overexpressed genes and proteins in specific
cell line cells. To represent the gene expression infor-
mation, we imported the object property “expresses”
from the Relations Ontology (RO) (http://purl.obolibrary.
org/obo/ro.owl) and built two object sub-properties
‘overexpresses gene’ and ‘overexpresses protein’ to specify
the overexpression of a gene and protein in cells, respec-
tively. Here genes are represented using terms from the
Ontology of Genes and Genomes (OGG) [22], and pro-
teins using Protein Ontology (PR) [23]. For example, we
generated the following axioms (Fig. 2b):
‘MDA-MB-231 cell’: ‘overexpresses gene’ some ‘WNT78’
‘MDA-MB-231cell’: ‘overexpresses protein’ some ‘EGFR’
Application of CLO-NICR to NICR service measurement
Based on the user purchase records in NICR, we found top
10 bestseller cells (Table 1). Most of the cells are cancer
related epithelial cells and derived from various anatom-
ical structures. It should be noted that BV2, 3T3-L1 and
293T cells are derived from in vitro genetic operations.
For example, 3T3-L1 is a cell line derived frommouse 3T3
cells. The 293T cell is a highly transfected derivative of
human embryonic kidney 293 cells, and contains the SV40
T-antigen. And the related cancer derived cells line are not
only involved in the study of cancer related mechanism,
such as inflammatory reaction, drug resistance, cell pro-
liferation, but also involved in the conventional research
of non-cancer related mechanism. Hence, we could not
specify the hotspots in cell line related cells or, but we
could have a better knowledge of the frequent used cell
line models in cell line related research. And for most of
the NICR cell line, more typical use case is needed since
that most are just in store state without any purchase
record. And with the statistics, we can have a better bud-
get forecast in manpower andmaterial resource allocation
in maintaining of all the NICR cells.
And in many cases, some frequently used cell lines are
cloned and stored in more than 2 repositories to benefit
the users in different region. To demonstrate depository
quantity and areal distribution of some frequently used
cell line models in NICR, we applied a DL query on CLO-
NICR under the Protégé-OWL editor platform (Fig. 3).
And the MCF 7 cell, a breast derived epithelial cells, was
used in the DL query. With Chinese label “ ”
for epithelial cell and Chinese label “ ” for breast, the
ontological axiom can be managed as follows:
‘derives from’ some (‘ ’ and (‘part of ’ some
‘ ’)
This query identified 10 cell line cell types, including
the original MCF7 cell in source CLO and 4 subclasses,
NICR13, NICR328, NICR822, NICR642 cells in NICR,
consistent with the data gathered in Table 1. Figure 3 also
provides a comprehensive explanation of NICR13 cell.
Specifically, this cell is derived from breast epithelial cells
from a human (i.e., “ ” in Chinese) patient who had
an invasive ductal carcinoma disease (i.e., “ ”
in Chinese). Figure 3 also shows that this NICR13 cell
is a subclass of the MCF7 cell (i.e., “MCF7 ”). Fur-
thermore, Fig. 3 shows MDA-MB-231 cell (i.e., “MDA-
MB-231 ”) and all its 4 NICR subclass cell types.
Such information can also be queried using SPARQL
query after the CLO-NCLR is deposited into a RDF triple
store [16].
Table 1 TOP 10 Bestseller cells in NICR
#No.
Cells Information
Cell line names Cell type Disease Anatomic entity
1 RAW 264.7 Monocyte Leukemia Blood
2 A549 Epithelial cell Lung cancer Lung
3 BV2 Microglia Immortalized transformation Central nervous system
4 CACO-2 Epithelial cell Colon cancer Colon
5 HepG2 Epithelial cell Liver cancer Liver
6 THP-1 Monocyte Leukemia Blood
7 MCF7 Epithelial cell Breast cancer Breast
8 SH-SY5Y Epithelial cell Neuroblastoma Bone marrow
9 3T3-L1 Fibroblast Immortalized transformation Embryo
10 293T Epithelial cell Immortalized transformation Kidney
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Fig. 3 DL Query for breast derived epithelial cell. The query was performed using Protégé DL Query
CLO-NICR visualization in Chinese in MedPortal
To benefit the application of CLO-NICR and CLO-NICR-
Cv, we have uploaded the CLO-NICR-Cv to MedPor-
tal (http://medportal.bmicc.cn) to accelerate the process
(Fig. 4). In order to support the visualization of Chi-
nese ontology in MedPortal in a proper semantically rich
and consistent manner [24], the labels and definitions
of annotation properties in CLO-NICR were translated
and refined. Users can browse online to search detailed
cell line cell information, browse the cell hierarchy, and
identify the relations among cells.
Disscusion
The contributions of this study are multiple-fold. First of
all, the representation of the 2704 cell line cells in NICR to
CLO-NICR standardizes the commonly used cell line cells
in China. The CLO-NICR framework provides us with the
basis for cell related data integration and systematic anal-
ysis. The addition of the CLO-NICR also extends the cov-
erage of CLO, and makes the cell lines commonly used in
China available for standard queries and analysis. Second,
this study extends the existing CLO design pattern and
builds an integrative ontological framework for represent-
ing all NICR cell line cells and their detailed information.
In modeling the framework of CLO-NICR, we extend
the design pattern to cover new information such as the
usage of cell line cells in cell transplantation for tumor
generation in model organisms, and overexpressed gene
and its products. The extended representation makes the
cell annotation more completed and definite. In addition,
CLO-NICR also includes more annotation properties and
linkage information to other cell resources, e.g., ChEMBL,
HyperCLDB, ATCC, Cellosaurus, and more bioinformat-
ics databases related with cell lines. Third, we are the first
to present CLO information using a bilanguage format.
Considering that most of the users are native Chinese and
the need for international promotion, we displayed the
CLO-NICR ontology by utilizing bilingual presentation to
fulfill the language need for the Chinese users. Fourth,
CLO-NICR view in Chinese could be properly rendered
in MedPortal, which is built by reusing the framework of
NCBO BioPortal. Thus the users in China can browse,
search, visualize and comment on ontologies through a
user-friendly Web interface, and programmatically, via
Web services. That will be helpful for promote the accep-
tance of CLO in China.
We have encountered many opportunities and chal-
lenges in our cross-language axioms generation and usage.
As shown in our “Results” section, we developed a strat-
egy to make our CLO-NICR available for Chinese users by
adding Chinese version of annotations such as term label
(rdfs:label). Our Chinese annotated terms are also shown
up in axioms. For example, the Chinese term ‘ ’
(i.e., cell separation) (OBI_0600037) is used in an axiom
as shown in Fig. 1. In this example, this term can be
expressed in Chinese as ‘ ’ or in English as ‘cell
separation’. Overall, the usage of either English or Chinese
does not affect the compatibility/equivalency of axioms
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Fig. 4 CLO-NICR views on MedPortal. Here showed some annotation properties for MCF7 cell specifically
when moving across different languages since either the
English of Chinese version uses the same ontology ID.
Our analysis shows that the axioms used with different
languages are compatible and equivalent in SPARQL. This
is because that ontology term ID (e.g., OBI_0600037) is
used in SPARQL query. However, such a selection affects
the DL query under the Protégé platform since the labels
instead of ontology IDs are used in DL query expres-
sion. And when we use a SPARQL query in Fig. 5 to
check the newly built NICR cell line number and the cor-
responding cell line label number, we found that 2704
NICR cells were integrated into the CLO-NICR with
5408 NICR cell line labels, consistent with the bilingual
terms label setting for each NICR cell line cell showed
in Fig. 1.
OntoChina (http://ontochina.org) is a newly initiated
program in China that aims to support the develop-
ment of reference ontologies, especially bilingual ontolo-
gies and Chinese translated ontologies, to establish an
integrative informatics framework for productive ontol-
ogy research and applications, and to promote the for-
mation of a collaborative biomedical ontology research
community. Many programs have been established under
OntoChina. For example, by adopting the National Center
for Biomedical Ontologies (NCBO) BioPortal technology,
we set up an ontology repository (http://medportal.bmicc.
cn) to accelerate the ontology application. Representing
the cell lines used in China in CLO is a part of OntoChina’s
mission to promote Chinese ontology development and
application. OntoChina has also translated the Basic For-
mal Ontology [25], the most commonly used upper ontol-
ogy in the OBO ontology community, into Chinese. Its
final version will be available in MedPortal after another
round of active peer reviewing. The related classes anno-
tated in Chinese have been imported into the CLO-NICR-
Cv version in MedPortal. We are translating several other
widely used ontologies, such as the IAO and the Ontol-
ogy for Biomedical Inverstigations (OBI) [26]. In addition,
the OntoChina team has established a collaborative rela-
tionship with the international OBO Foundry, and more
collaborative projects are anticipated in the near future.
Conclusion
In summary, all identified cell lines from NICR are rep-
resented by the semantics framework of CLO and incor-
porated into CLO as a most recent update. We also
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Fig. 5 SPARQL query of the number of NICR cell lines and the corresponding cell line labels. The query was performed using Protégé SPARQL Query
generated a CLO-NICR and its Chinese view (CLO-
NICR-Cv). The development of CLO-NICR and CLO-
NIC-Cv allows the integration of the cell lines from NICR
into the community-based CLO ontology and provides an
integrative platform to support different applications of
CLO in China.
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